8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - BIOMARIN PHARMACEUTICAL filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
Directly affected
- BMRN Biomarin Pharmaceutical-6.9% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+19.9% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.9% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+7.3% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+5.9% 19d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| BMRN | -3.66% | -0.09% | base | -3.10% | -0.54% | -2.35% | after close |
| XLV | -3.14% | -0.51% | base | -0.34% | +2.73% | +0.31% | after close |
| XBI | +1.64% | +3.59% | base | +1.89% | +4.64% | -2.40% | after close |
| LLY | -9.70% | -3.22% | base | -0.17% | +0.45% | -2.64% | after close |
| JNJ | -1.08% | +1.28% | base | -1.63% | +2.13% | +0.67% | after close |
| PFE | -3.81% | -3.29% | base | -2.38% | +0.26% | -2.70% | after close |
| MRK | -4.78% | -1.78% | base | -2.55% | +1.29% | -0.75% | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-02 AccNo: 0001048477-26-000021 Size: 832 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Biomarin Pharmaceutical (BMRN) since “8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer),” compared with the market
Since the first closing price after “8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer),” Biomarin Pharmaceutical (BMRN) is +2.59%.
| Company | When | Move | Status |
|---|---|---|---|
| Biomarin Pharmaceutical (BMRN) | that day | -3.10% | final price |
| Biomarin Pharmaceutical (BMRN) | the next day | -0.54% | final price |
| Biomarin Pharmaceutical (BMRN) | two days later | -2.35% | final price |
| Biomarin Pharmaceutical (BMRN) | three days earlier | -0.09% | final price |
| Biomarin Pharmaceutical (BMRN) | five days earlier | -3.66% | final price |
| Johnson & Johnson (JNJ) | that day | -1.63% | final price |
| Johnson & Johnson (JNJ) | the next day | +2.13% | final price |
| Johnson & Johnson (JNJ) | two days later | +0.67% | final price |
| Johnson & Johnson (JNJ) | three days earlier | +1.28% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -1.08% | final price |
| Eli Lilly (LLY) | that day | -0.17% | final price |
| Eli Lilly (LLY) | the next day | +0.45% | final price |
| Eli Lilly (LLY) | two days later | -2.64% | final price |
| Eli Lilly (LLY) | three days earlier | -3.22% | final price |
| Eli Lilly (LLY) | five days earlier | -9.70% | final price |
| Merck (MRK) | that day | -2.55% | final price |
| Merck (MRK) | the next day | +1.29% | final price |
| Merck (MRK) | two days later | -0.75% | final price |
| Merck (MRK) | three days earlier | -1.78% | final price |
| Merck (MRK) | five days earlier | -4.78% | final price |
| Pfizer (PFE) | that day | -2.38% | final price |
| Pfizer (PFE) | the next day | +0.26% | final price |
| Pfizer (PFE) | two days later | -2.70% | final price |
| Pfizer (PFE) | three days earlier | -3.29% | final price |
| Pfizer (PFE) | five days earlier | -3.81% | final price |
| Spdr Series Trust (XBI) | that day | +1.89% | final price |
| Spdr Series Trust (XBI) | the next day | +4.64% | final price |
| Spdr Series Trust (XBI) | two days later | -2.40% | final price |
| Spdr Series Trust (XBI) | three days earlier | +3.59% | final price |
| Spdr Series Trust (XBI) | five days earlier | +1.64% | final price |
| Select Sector Spdr Tr (XLV) | that day | -0.34% | final price |
| Select Sector Spdr Tr (XLV) | the next day | +2.73% | final price |
| Select Sector Spdr Tr (XLV) | two days later | +0.31% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -0.51% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -3.14% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 33 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 75 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Biomarin Pharmaceutical (BMRN)
Companies carried with this story
- BMRN Biomarin Pharmaceutical
For “8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer),” Biomarin Pharmaceutical (BMRN) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> BMRN
- XLV Select Sector Spdr Tr
Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer).” Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- XBI Spdr Series Trust
In “8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer),” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
- LLY Eli Lilly
In “8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer),” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- JNJ Johnson & Johnson
In “8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer),” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- PFE Pfizer
Pfizer (PFE) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer).” Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
- MRK Merck
For “8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story
How “8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)” reaches Biomarin Pharmaceutical (BMRN)
“8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)” (2 Nov 2026) reaches Biomarin Pharmaceutical (BMRN) through this story.
Biomarin Pharmaceutical (BMRN) is on the page because SEC 8-K filing -> direct issuer disclosure -> BMRN
Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story
Dates in the story, and the Biomarin Pharmaceutical (BMRN) price range
BMRN traded between 52.88 and 59.40 across 20 sessions. The latest close on file is 57.13.
How strong the case is around Biomarin Pharmaceutical (BMRN)
46 out of 100
“8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.